Healsglobe Exports Private Limited

Anaridex (Anastrozole) is a potent aromatase inhibitor used to treat hormone receptor-positive breast cancer in postmenopausal women. By lowering estrogen levels, Anastrozole helps slow down or stop the growth of cancer cells that rely on estrogen to grow.

Indications:

• Hormone receptor-positive breast cancer in postmenopausal women
• Adjuvant treatment of early breast cancer
• Treatment of advanced breast cancer

Dosage and Administration:
Typically, Anaridex is taken once daily, with or without food, as prescribed by a healthcare provider. The standard dose is 1 mg per day.

Common side effects include:

• Hot flashes
• Fatigue
• Joint pain
• Osteoporosis

Packaging:
Anaridex is available in blister packs containing 10 tablets each.

Ondem 4 Tablet contains Ondansetron 4 mg, a selective serotonin 5-HT3 receptor antagonist. It is primarily used to prevent and treat nausea and vomiting associated with cancer treatments like chemotherapy and radiotherapy, as well as post-operative nausea. By blocking the actions of chemicals that can trigger nausea, Ondem helps ensure patient comfort during medical procedures.

Popular brands like Ondem, Emeset, and Zofran are commonly prescribed for managing nausea and vomiting across various clinical settings. Manufactured by Alkem Laboratories Ltd, Ondem 4 Tablet provides reliable support in preventing nausea and improving patient outcomes

Tamoxifen Tablets 20 Mg is a medication used to treat hormone-sensitive breast cancer in women. It works by blocking the effects of estrogen, a hormone that can promote the growth of breast cancer cells.

Tamobix 20 MG is a medication used in the treatment of breast cancer. It works by blocking the effects of estrogen, a hormone that can stimulate the growth of certain types of breast cancer cells.

Lenalid 15 Capsule contains Lenalidomide, an immunomodulatory agent that is primarily used in the treatment of certain types of cancers, including multiple myeloma, myelodysplastic syndromes (MDS), and mantle cell lymphoma. Lenalidomide works by affecting the immune system to inhibit the growth of cancer cells, promote the destruction of abnormal cells, and reduce the formation of blood vessels that supply tumors.

Common indications for Lenalid 15 Capsule include:

• Multiple Myeloma: Used in combination with other medications to treat multiple myeloma, particularly in patients who have received at least one prior therapy.
• Myelodysplastic Syndromes (MDS): Used to treat certain types of MDS, especially in patients with a specific chromosomal abnormality.
• Mantle Cell Lymphoma: Used in patients whose disease has relapsed or progressed after two prior therapies, including bortezomib.

Dosage and Administration:

• For Adults: The dosage of Lenalid 15 Capsule varies depending on the condition being treated. The exact dosage regimen should be determined by a healthcare provider based on individual patient factors and response to treatment.
• Administration: The capsule should be swallowed whole with water, with or without food. It is important to follow the prescribed schedule and not to break, chew, or open the capsules.

Common side effects of Lenalid 15 Capsule may include:

• Fatigue
• Anemia
• Neutropenia (low white blood cell count)
• Thrombocytopenia (low platelet count)
• Diarrhea
• Rash

Due to the risk of serious side effects, including birth defects, Lenalidomide is subject to special safety monitoring and prescribing programs. Patients should discuss all potential risks and benefits with their healthcare provider.

Packaging:
Lenalid 15 Capsule is typically packaged in blister packs containing 10 capsules, providing a convenient form for daily or cyclical use as prescribed by a healthcare provider.

Lenalid 15 Capsule is a critical medication in the management of certain hematological cancers, offering a targeted approach to treatment that leverages the body's immune system to fight disease. Its use in conditions like multiple myeloma and MDS has significantly improved outcomes for many patients, though it requires careful monitoring and adherence to prescribed safety protocols.

A 100mg tablet of Imatinib Mesylate is an oral medication primarily used to treat certain types of cancer. It belongs to a class of drugs called tyrosine kinase inhibitors. Imatinib works by blocking the action of specific proteins, particularly an enzyme called Bcr-Abl tyrosine kinase. This enzyme is often overactive in certain cancer cells, promoting their growth and spread. By inhibiting this enzyme, Imatinib helps to slow down or stop the growth of these cancer cells and can even cause them to die.

Xmalon 25mg Tablet is also used in combination with medication in early cancer to prevent the risk of coming back. It should be taken with food, but take it at the same time every day to get the most benefit. It should be taken as your doctor's advice. The dose and how often you take it depends on what you are taking it for. Your doctor will decide how much you need to improve your symptoms. Swallow the tablets whole with a drink of water. You should take this medicine for as long as it is prescribed for you.

The most common side effects of the medicine include insomnia (difficulty sleeping), headache, nausea, increased appetite, and joint pain  If these bother you, or appear serious, let your doctor know. There may be ways of reducing or preventing them.

• Calutide 50mg (Genric Casodex) is an anti-androgen. It works in the body by preventing the actions of androgens (male hormones)
• Calutide 50mg (Genric Casodex) is used together with another hormone to treat prostate cancer
• Calutide 50mg (Genric Casodex) may also be used for purposes not listed in this medication guide
• Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficult breathing; swelling of your face, lips, tongue, or throat
• Oral consumption
• permitted chemical compounds
• Competitive prices

Short Description

Lenalid 25mg is a prescription medication used to treat certain types of blood cancers, including multiple myeloma and myelodysplastic syndromes (MDS). It works by stimulating the immune system to fight cancer cells.  

Letrozole 2.5mg Tablets are a type of medication used to treat hormone-receptor-positive breast cancer in postmenopausal women.  

Uses:

• Treats hormone-receptor-positive breast cancer in postmenopausal women.  
• Reduces the risk of breast cancer recurrence in postmenopausal women with early-stage breast cancer.

Sutinat 12.5 is a targeted therapy medication used to treat certain types of cancer, including kidney cancer, gastrointestinal stromal tumors (GIST), and pancreatic neuroendocrine tumors (pNET). It works by blocking specific enzymes that promote the growth and spread of cancer cells. 

Bicatero 50 Bicalutamide is a non-steroidal antiandrogen medication used in the treatment of prostate cancer. It works by blocking the effects of testosterone, a hormone that promotes prostate growth and cancer cell development.

Testoviron Depot 100 is a long-acting testosterone injection used to treat testosterone deficiency in men. It helps to restore normal testosterone levels and address symptoms such as fatigue, low libido, and erectile dysfunction.

Sutinat 25 is a targeted cancer therapy medication used to treat certain types of advanced cancers. It works by blocking the growth and spread of cancer cells.

Sutinat 50 is a targeted cancer therapy medication used to treat certain types of advanced cancers. It works by blocking the growth of blood vessels that supply tumors, inhibiting the growth and spread of cancer cells.

Nubeqa 300mg tablet consists of the active ingredient Darolutamide. It is an androgen receptor inhibitor used for treating adult men with non-metastatic castration-resistant prostate cancer. It is also approved to treat hormone-sensitive metastatic prostate cancer in combination with other anti-cancer medications. Prostate cancer occurs when the prostate cells start multiplying and dividing abnormally. Do not take this medicine if you are allergic to darolutamide or any other ingredient in it.    

Effective contraception is to be taken while using Nubeqa 300mg Tablet, and it must be continued till one week after the last dose with this medication to prevent pregnancy. Before starting treatment with this medication, inform your doctor if you have any liver problems, kidney problems, heart conditions, or allergic conditions.  

Nubeqa 300mg tablet may cause infertility in men, hence discuss your fertility concerns with your doctor before beginning treatment with this medication. Inform your doctor if you are lactose intolerant before starting treatment with this medication, as it contains lactose. Fatigue, rash, and pain in muscle, bone, arms, and legs are common side effects of this medication. 

• Non-metastatic, castration-resistant prostate cancer (prostate cancer that hasn’t spread to other body parts and does not respond to medicinal or surgical treatment)
• Hormone-sensitive metastatic prostate cancer in combination with other anti-cancer medications.

Therapeutic Effects of Nubeqa 300mg Tablet

Nubeqa 300mg tablet works by inhibiting the activity of androgens (testosterone) which are male sex hormones. Inhibition of these hormones stops the growth, division and multiplication of cancer cells. 

Inform your doctor about any prescription medications, over-the-counter medications, nutritional or vitamin supplements, and herbal products that you are taking or have taken before the treatment. Certain medicines may interact with Nubeqa 300mg tablet and can cause undesirable side effects. 

• Keep Darolutamide out of sight and reach of children.
• This medication is to be stored at or below 30 °C.
• If you missed your regular dose, take it as soon as you remember. If it is 2 hours or less before your next dose, do not take the missed dose.  Inform your physician about the missed dose. Do not take 2 doses at the same time.

Nubeqa 300mg tablet is to be taken exactly as prescribed by your healthcare provider. Swallow this medication whole with food and water. The frequency of administration will be decided by your doctor based on the severity. 

Bracanat 150mg Tablet contains Olaparib, a poly (ADP-ribose) polymerase (PARP) inhibitor used in the treatment of various cancers, particularly those associated with BRCA gene mutations. Olaparib works by blocking the PARP enzyme, which helps repair damaged DNA in cells. By inhibiting this enzyme, Olaparib prevents cancer cells from repairing themselves, leading to their death.

Common indications for Bracanat 150mg Tablet include:

• Ovarian Cancer: Used in the maintenance treatment of adult patients with advanced ovarian cancer who have responded to first-line platinum-based chemotherapy.
• Breast Cancer: Used in the treatment of HER2-negative breast cancer with BRCA1/2 mutations.
• Pancreatic Cancer: Used in the maintenance treatment of BRCA-mutated metastatic pancreatic cancer.
• Prostate Cancer: Used in the treatment of metastatic castration-resistant prostate cancer with BRCA1/2 mutations.

Dosage and Administration:

• For Adults: The usual recommended dose is 300 mg (two 150 mg tablets) taken orally twice daily, for a total daily dose of 600 mg.
• Administration: The tablet should be swallowed whole with water, taken at approximately the same times each day, with or without food. It should not be crushed, chewed, or split.

Common side effects of Bracanat 150mg Tablet may include:

• Nausea
• Fatigue
• Anemia
• Vomiting
• Diarrhea
• Loss of appetite

Regular blood tests and monitoring are essential during treatment to manage potential side effects and adjust the dosage as needed.

Packaging:
Bracanat 150mg Tablet is typically packaged in blister packs containing 14 tablets, designed for a one-week course of treatment when taken as prescribed.

Bracanat 150mg Tablet is a significant advancement in cancer treatment, offering targeted therapy for patients with specific genetic mutations. It plays a crucial role in extending survival and improving the quality of life for patients with certain types of advanced cancers, particularly those associated with BRCA mutations. Regular monitoring and adherence to the prescribed regimen are vital to achieving the best possible outcomes.

 Silofast 8mg Capsules contain Silodosin 8mg, a selective alpha-1 adrenergic receptor antagonist that is primarily used to treat symptoms of benign prostatic hyperplasia (BPH), a non-cancerous enlargement of the prostate gland in men. By relaxing the muscles in the prostate and bladder neck, Silodosin helps relieve symptoms such as difficulty in urination, a weak urine stream, and frequent or urgent urination, allowing smoother urine flow.

Silofast is highly effective in improving urinary symptoms and quality of life for men with BPH. It specifically targets the alpha-1A receptors in the prostate, minimizing the effect on blood pressure compared to other alpha-blockers. This makes it suitable for older patients or those with comorbidities.

Common side effects include dizziness, retrograde ejaculation (where semen enters the bladder instead of exiting through the penis), and a runny or stuffy nose. It is advised to take the capsule with food to reduce the risk of side effects, and patients should avoid operating heavy machinery or driving until they know how the medication affects them.

Silofast 8mg should be used under medical supervision, and patients are encouraged to consult their healthcare provider if they experience any severe side effects or if their symptoms do not improve. Regular follow-ups may be necessary to monitor the progression of BPH and the effectiveness of the treatment.Silofast is highly effective in improving urinary symptoms and quality of life for men with BPH. It specifically targets the alpha-1A receptors in the prostate, minimizing the effect on blood pressure compared to other alpha-blockers. This makes it suitable for older patients or those with comorbidities.